MicroRNA is demonstrated to be present in the blood of humans and has been increasingly suggested as a novel biomarker for various pathological processes in the heart,including myocardial infarction,m
Objectives: To determine the upper limits of the 95th percentile reference intervals(RIs)for the detection of the serum pro-gastrin releasing peptide(ProGRP)according to the Clinical and Laboratory St
Aims: Amino terminal pro-brain natriuretic peptide(NT-proBNP)testing in the emergency department(ED)is used to rule out and rule in acute heart failure(HF).
Aim:To validate the Kidney Disease:Improving Global Outcomes(KDIGO)guidelines risk stratification system basedon the combination of eGFR and proteinuria.